New York Life Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Sell |
2,103
-111
| -5% | -$36.2K | 0.01% | 711 |
|
|
2025
Q1 | $598K | Sell |
2,214
-170
| -7% | -$45.9K | 0.01% | 753 |
|
|
2024
Q4 | $561K | Buy |
2,384
+153
| +7% | +$36K | 0.01% | 774 |
|
|
2024
Q3 | $614K | Sell |
2,231
-32
| -1% | -$8.8K | 0.01% | 794 |
|
|
2024
Q2 | $550K | Buy |
2,263
+45
| +2% | +$10.9K | 0.01% | 796 |
|
|
2024
Q1 | $331K | Buy |
2,218
+20
| +0.9% | +$2.99K | ﹤0.01% | 1297 |
|
|
2023
Q4 | $421K | Sell |
2,198
-28
| -1% | -$5.36K | ﹤0.01% | 958 |
|
|
2023
Q3 | $394K | Sell |
2,226
-187
| -8% | -$33.1K | ﹤0.01% | 888 |
|
|
2023
Q2 | $458K | Sell |
2,413
-90
| -4% | -$17.1K | ﹤0.01% | 791 |
|
|
2023
Q1 | $501K | Buy |
2,503
+90
| +4% | +$18K | 0.01% | 671 |
|
|
2022
Q4 | $573K | Sell |
2,413
-29
| -1% | -$6.89K | 0.01% | 806 |
|
|
2022
Q3 | $489K | Sell |
2,442
-283
| -10% | -$56.7K | 0.01% | 760 |
|
|
2022
Q2 | $397K | Buy |
+2,725
| New | +$397K | ﹤0.01% | 974 |
|